Suhayl Dhib-Jalbut from Rutgers University: Applying Personalized Medicine to Multiple Sclerosis Care

Video

Throughout medicine personalized care is becoming an increasing focus of the field. This is no exception for the treatment of multiple sclerosis where patients may find a medication which works for a short time before needing to find a new option.

Throughout medicine personalized care is becoming an increasing focus of the field. This is no exception for the treatment of multiple sclerosis where patients may find a medication which works for a short time before needing to find a new option.

Suhayl S. Dhib-Jalbut, MD, from Rutgers University, discussed what this approach can mean for patient care during the annual meeting of the Consortium of Multiple Sclerosis Centers, in National Harbor, Maryland. The doctor noted that with no one-size-fits-all approach to treating multiple sclerosis, it is important to look at a variety of potential treatment options to help patients manage their symptoms.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.